Shenzhen New Industries Biomedical (300832.SZ) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Equipment · China · ISIN CNE100003T39

Price
53.10 CNY
Market cap
41.72 bn CNY
P/E (2025)
25.75
P/S (2025)
9.12
Dividend yield
2.26 %
Net margin
35.40 %
Return on equity (ROE)
17.72 %
Return on assets (ROA)
16.30 %

Shenzhen New Industries Biomedical financials

Fiscal year20242025
Revenue4.54 bn CNY4.58 bn CNY
Gross profit3.27 bn CNY3.17 bn CNY
Operating income2.11 bn CNY1.81 bn CNY
EBIT1.93 bn CNY1.86 bn CNY
Net income1.83 bn CNY1.62 bn CNY
Diluted EPS – continuing operations2.33 CNY2.06 CNY

Full history since 2012, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Shenzhen New Industries Biomedical

Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally. It offers immunoassay analyzers, biochemistry/electrolyte, integrated system, lab automation, molecular diagnostics, hemolumi and rapid test solutions. The company was founded in 1995 and is based in Shenzhen, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 20.10.2026. Details in the risk notice.

Shenzhen New Industries Biomedical stock (300832.SZ): P/E, revenue, dividend | finmetric